Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art
Cytomegalovirus (CMV) is the most common cause of congenital infection and non-genetic sensorineural hearing loss in childhood. Up to 2% of neonates, with the highest percentages found in developing countries, are congenitally infected with CMV. At birth, most of these infants are asymptomatic. Howe...
Main Authors: | Susanna Esposito, Giulia Chiopris, Giulia Messina, Tiziana D’Alvano, Serafina Perrone, Nicola Principi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/5/523 |
Similar Items
-
Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice
by: Sara Scarpini, et al.
Published: (2021-05-01) -
Congenital Cytomegalovirus Infection: Update on Diagnosis and Treatment
by: Giulia Chiopris, et al.
Published: (2020-10-01) -
Development and Assessment of a Prenatal Cytomegalovirus (CMV) Educational Survey: Implementation and Impact in a Metropolitan University-Based Clinic
by: Schaefer MR, et al.
Published: (2020-12-01) -
Short- and long-term impact of vaccination against cytomegalovirus: a modeling study
by: Ganna Rozhnova, et al.
Published: (2020-07-01) -
Cytomegalovirus vaccines under clinical development
by: Mark R. Schleiss
Published: (2016-10-01)